PhewyPompipi的个人主页 - 老虎社区

PhewyPompipi

PhewyPompipi

暂无个人介绍

IP属地：未知

12关注

9粉丝

0主题

0勋章

2021-08-16

$BioNTech SE(BNTX)$what is happening? Why was it doing well last week and today opening mkt and it sink so bad?

2021-07-30

$Pinterest, Inc.(PINS)$OMG! SOMEONE PLEASE TELL me this stock will soar soon and not plummet further...to sell or not to sell now?

2021-09-28

$BioNTech SE(BNTX)$time to faint???

2021-11-12

$BioNTech SE(BNTX)$Seriously? Why is this tanking when more vaccines are needed now for 3rd booster shots as well as for 5 - 11yo? Frustrating...😑

2021-08-12

Fantastic positive news! Keeping fingers crossed!

BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>

2021-07-29

$Lemonade, Inc.(LMND)$sigh...any chance of a lift-up?

2021-07-04

Good article, thanks!

抱歉，原内容已删除

2021-09-20

$Apple(AAPL)$Just dipped to my buying price...is this gonna stay like that for the next few days...or weeks...?

2021-08-30

$Apple(AAPL)$Could it go up to $159?/$160 mark? 😍

2021-11-05

Wth...

Vaccine stocks slipped after Pfizer announced its good news<blockquote>辉瑞宣布好消息后疫苗股下跌</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087475573507020","uuid":"4087475573507020","gmtCreate":1624372765357,"gmtModify":1624500741691,"name":"PhewyPompipi","pinyin":"phewypompipi","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":12,"tweetSize":40,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.74%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":609590806,"gmtCreate":1638291592848,"gmtModify":1638291592918,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"BioNTech has good potential. So there's really no reason for investors to dump the stock. Once the test results are out, prepare for it to soar!","listText":"BioNTech has good potential. So there's really no reason for investors to dump the stock. Once the test results are out, prepare for it to soar!","text":"BioNTech has good potential. So there's really no reason for investors to dump the stock. Once the test results are out, prepare for it to soar!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609590806","repostId":"1190156196","repostType":4,"repost":{"id":"1190156196","kind":"news","pubTimestamp":1638242388,"share":"https://www.laohu8.com/m/news/1190156196?lang=zh_CN&edition=full","pubTime":"2021-11-30 11:19","market":"us","language":"en","title":"5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market<blockquote>随着新的Covid-19变种袭击市场，值得关注的5只疫苗股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1190156196","media":"InvestorPlace","summary":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race","content":"<p><div> Here are the stocks to watch as the omicron variant gives rise to a new vaccine race Source: Shutterstock As Black Friday approached, most investors were speculating on what the supply chain crisis ...</p><p><blockquote><div>随着奥密克戎变种引发新的疫苗竞赛，以下是值得关注的股票来源：Shutterstock随着黑色星期五的临近，大多数投资者都在猜测供应链危机……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market<blockquote>随着新的Covid-19变种袭击市场，值得关注的5只疫苗股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market<blockquote>随着新的Covid-19变种袭击市场，值得关注的5只疫苗股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-11-30 11:19</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Here are the stocks to watch as the omicron variant gives rise to a new vaccine race Source: Shutterstock As Black Friday approached, most investors were speculating on what the supply chain crisis ...</p><p><blockquote><div>随着奥密克戎变种引发新的疫苗竞赛，以下是值得关注的股票来源：Shutterstock随着黑色星期五的临近，大多数投资者都在猜测供应链危机……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/11/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190156196","content_text":"Here are the stocks to watch as the omicron variant gives rise to a new vaccine race\nSource: Shutterstock\nAs Black Friday approached, most investors were speculating on what the supply chain crisis would mean for the year’s biggest shopping holiday. By the time shopping began, though, most minds were on another news story. A new Covid-19 variant had been detected in South Africa and it was quickly spreading to Europe. Labeled the omicron variant, this new Covid-19 strain poses a threat to the pandemic recovery story. Perhaps most importantly, we don’t yet know how big that threat is. Scientists haveindicatedthat it will take at least a few weeks for them to assess the effectiveness of vaccines against the new variant, which features multiple mutations. As investors ponder what this means for markets, focus has shifted to one specific question: What does this mean for vaccine stocks?\nInvestors have expressed concern at what the the emergence of a new variant may mean for markets. It bears noting, though, that such a scenario creates a new opportunity for vaccine stocks, specifically for a new company to pull into the lead.\nWhile Pfizer’s(NYSE:PFE) success in producing a vaccine approved for children has helped it maintain a lead over its competitors, other companies recognize the need for further innovation within the vaccine space. Scientists and researchers have yet to reach a conclusion as to how the new variant will react to current vaccines, but the companies producing them are already working around the clock.\nMany vaccine stocks were trending this morning as the omicron variant dominated news coverage. Let’s take a look at what the most prominent vaccine producers are saying and when we can expect to see progress.\n\nModerna(NASDAQ:MRNA)\nPfizer(NYSE:PFE)\nBioNTech (NASDAQ:BNTX)\nJohnson & Johnson(NYSE:JNJ)\nNovavax(NASDAQ:NVAX)\n\nModerna (MRNA)\nModerna was one of the first companies to have its executive team discuss address the omicron variant.\nOn Sunday, CMO Paul Burton spoke toBBC’sAndrew Marr and said Moderna was hoping to see clinical trials of an omicron-specific booster begin within60 to 90 days. CEO Stephane Bancel recentlyspoketoCNBC’s“Squawk Box” on the topic of an omicron- targeting vaccine. While he stated that it will likely take months for the company to develop, produce and ship a vaccine with the ability to target that specific variant, he noted that a booster shot containing a higher 100-microgram dose could be made available much sooner.\nBancel also floated the possibility of administering higher doses of the current vaccines to particularly high-risk patients, such as those in the elderly or immunocompromised categories.\nThis talk of an effective booster that could take on the new variant has sent MRNA stock shooting up today. As of this writing, vaccine stocks are having a good day and Moderna has risen by more than 10%. Today’s gains have put it up by more than 30% for the past five days.\nWhile the head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.\n\"There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,\" Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.\n\"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like 'this is not going to be good.'\"\nPfizer (PFE)\nNo pharmaceutical company has received as much positive press for its vaccine innovations as Pfizer. Earlier this month, CEO Albert Bourla wasrecommended by one InvestorPlace contributorfor CEO of the year.\nThe industry leader alsodiscussedthe new variant earlier today, stating that he believed that Pfizer’s Covid-19 pill would prove effective against it. He noted that the treatment method was designed with the thought process that most virus mutations were coming in spikes, exactly what we are seeing so far from the omicron variant. This gives him, he said, a “very high level of confidence” that the oral treatment, Paxlovid, will prove well-suited to help patients with the new Covid-19 strain.\nClinical trials have found that when Paxlovid is taken with HIV drug ritonavir, it reduces hospitalization and death by 89% if taken within three days after symptoms have begun.\nWhile Bourla is still not able to offer much on the effectiveness of the company’s two-dose vaccine against the new variant, he experts it to offer at least some protection. He also said that Pfizer is already at work on a new vaccine and that it produced a DNA template on Friday, speculating that it could be ready within 100 days.\nIt is worth noting that Pfizer has been able to create vaccines for previous variants in that timeframe but did not end up having to administer them, as the previously distributed vaccines remained effective.\nBioNTech (BNTX)\nPfizer’s original vaccine partner isn’t missing a beat, either.\nThe German biotech innovatortoldBusiness Insiderthat it is already at work on the development of an adapted vaccine to combat the omicron variant. According to the company’s spokespeople, the first steps of such a process “overlap with the research necessary” to evaluate the necessity of a new shot. This approach should enable its research team to move forward as quickly as possible.\nLike its competitors, BioNTech expects to acquire the data necessary to determine next steps in roughly two weeks, as medical researchers rush to examine new cases. In an attempt to keep the process as efficient as possible, the company is already testing its existing vaccine doses. Like Pfizer, it claims that it will be able to ship out this adapted vaccine within 100 days should it prove necessary.\nLike other vaccine stocks, BNTX is having a good day as speculation regarding the vaccine mounts. Shares are up almost 4% as of this writing. Not unlike its competitor Moderna, BioNTech is up almost 20% for the week after seeing a period of mostly flatlining. Earlier this Summer,InvestorPlace analyst Louis Navelliercalledit a better buy among vaccine stocks than Pfizer.\nJohnson & Johnson (JNJ)\nLike its competitors, Johnson & Johnson is already at work on ways to combat the new variant. Still waiting on further data, though, the company hasstatedit “will progress [its new vaccine] into clinical studies if needed.”\nMathai Mammen, global head of research and development at J&J subsidiary Janssen Pharmaceuticals, says that the company remains confident in the “robust humoral and cell-mediated responses” that its original vaccine has elicited in patients to date, giving the company confidence in its ability to adapt its current vaccine to handle the omicron variant.\nMammen added that the company has already begun work on a new vaccine for exactly that purpose and will “rapidly progress into clinical trails” if it is deemed necessary. It has beenreportedthat testing has already begun.\nNovavax (NVAX)\nA later player to the vaccine race, Novavax hasn’t had the same success in the U.S. as Pfizer or Moderna.\nHowever, the company recognizes it has a chance to make up the lost ground. In fact, it is already working to develop a vaccine to combat the omicron variant. Novavax hasstatedthat its vaccine will contain the mutated spikes that have experts worried about the variant, thereby enabling recipients to develop necessary immune responses. Its spokespeople have also stated that the testing and developing of the new vaccine will likely take “a few weeks.”\nWhile Novavax has not filed for approval for its initial Covid-19 in the U.S. yet, it received the green light from regulators in both Indonesia and the Philippines.\nAs InvestorPlace Assistant News Writer Eddie Pan reported this morning, NVAX is a name to watch among vaccine stocks as speculation mounts. While no one is likely to know too much for at least two weeks, companies aren’t wasting any time in building on their vaccine innovations in attempt to pull ahead in the vaccine race. Novavax may not have garnered U.S. authorization yet, but it has risen to prominence by way of its global vaccine distribution work, an edge that earned it ahigh rankingamong second-shot vaccine stocks to buy.","news_type":1,"symbols_score_info":{"MRNA":0.9,"JNJ":0.9,"BNTX":0.9,"PFE":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":1940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600451700,"gmtCreate":1638191764950,"gmtModify":1638191765142,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"It's all good news to us investors.&nbsp;","listText":"It's all good news to us investors.&nbsp;","text":"It's all good news to us investors.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600451700","repostId":"1173904581","repostType":4,"isVote":1,"tweetType":1,"viewCount":1549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870746623,"gmtCreate":1636655711171,"gmtModify":1636655711386,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Seriously? Why is this tanking when more vaccines are needed now for 3rd booster shots as well as for 5 - 11yo? Frustrating...😑","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Seriously? Why is this tanking when more vaccines are needed now for 3rd booster shots as well as for 5 - 11yo? Frustrating...😑","text":"$BioNTech SE(BNTX)$Seriously? Why is this tanking when more vaccines are needed now for 3rd booster shots as well as for 5 - 11yo? Frustrating...😑","images":[{"img":"https://static.tigerbbs.com/7023799f8e65f048e38dc8f783b6a876","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/870746623","isVote":1,"tweetType":1,"viewCount":2451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846771824,"gmtCreate":1636118254704,"gmtModify":1636118931968,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Wth...","listText":"Wth...","text":"Wth...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846771824","repostId":"1196545101","repostType":2,"repost":{"id":"1196545101","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636114848,"share":"https://www.laohu8.com/m/news/1196545101?lang=zh_CN&edition=full","pubTime":"2021-11-05 20:20","market":"us","language":"en","title":"Vaccine stocks slipped after Pfizer announced its good news<blockquote>辉瑞宣布好消息后疫苗股下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1196545101","media":"Tiger Newspress","summary":"Vaccine stocks slipped after Pfizer announced his good news.Pfizer said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.BioNTech SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly and AstraZeneca fell between 1% and 11%.Whlie Pfizer surged 12% in premarket trading.","content":"<p>Vaccine stocks slipped after Pfizer announced his good news.Pfizer&nbsp;said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.</p><p><blockquote>辉瑞宣布他的好消息后，疫苗股下滑。辉瑞表示，其Covid-19药丸将高危患者的住院和死亡人数减少了89%。</blockquote></p><p> BioNTech&nbsp;SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 11%.Whlie&nbsp;Pfizer&nbsp;surged&nbsp;12%&nbsp;in premarket trading.</p><p><blockquote>BioNTech SE、Moderna、Novavax、默克、再生元制药、Vir Biotechnology、Inovio Pharmaceuticals、吉利德科学、礼来和AstraZeneca跌幅在1%至11%之间。辉瑞在盘前交易中飙升12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8a70ae8e53167b1da5670c9bd985e930\" tg-width=\"402\" tg-height=\"664\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks slipped after Pfizer announced its good news<blockquote>辉瑞宣布好消息后疫苗股下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks slipped after Pfizer announced its good news<blockquote>辉瑞宣布好消息后疫苗股下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-05 20:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks slipped after Pfizer announced his good news.Pfizer&nbsp;said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.</p><p><blockquote>辉瑞宣布他的好消息后，疫苗股下滑。辉瑞表示，其Covid-19药丸将高危患者的住院和死亡人数减少了89%。</blockquote></p><p> BioNTech&nbsp;SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 11%.Whlie&nbsp;Pfizer&nbsp;surged&nbsp;12%&nbsp;in premarket trading.</p><p><blockquote>BioNTech SE、Moderna、Novavax、默克、再生元制药、Vir Biotechnology、Inovio Pharmaceuticals、吉利德科学、礼来和AstraZeneca跌幅在1%至11%之间。辉瑞在盘前交易中飙升12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8a70ae8e53167b1da5670c9bd985e930\" tg-width=\"402\" tg-height=\"664\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","PFE":"辉瑞","BNTX":"BioNTech SE","VIR":"Vir Biotechnology, Inc.","REGN":"再生元制药公司","NVAX":"诺瓦瓦克斯医药","LLY":"礼来","INO":"伊诺维奥制药","MRK":"默沙东","MRNA":"Moderna, Inc.","GILD":"吉利德科学"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196545101","content_text":"Vaccine stocks slipped after Pfizer announced his good news.Pfizer said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.\nBioNTech SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly and AstraZeneca fell between 1% and 11%.Whlie Pfizer surged 12% in premarket trading.","news_type":1,"symbols_score_info":{"MRNA":0.9,"LLY":0.9,"GILD":0.9,"BNTX":0.9,"MRK":0.9,"NVAX":0.9,"AZN":0.9,"PFE":0.9,"VIR":0.9,"REGN":0.9,"INO":0.9}},"isVote":1,"tweetType":1,"viewCount":2308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853477115,"gmtCreate":1634832939308,"gmtModify":1634832939535,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>up and up yeah!&nbsp;Good momentum, BioNTech, keep it going!","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>up and up yeah!&nbsp;Good momentum, BioNTech, keep it going!","text":"$BioNTech SE(BNTX)$up and up yeah! Good momentum, BioNTech, keep it going!","images":[{"img":"https://static.tigerbbs.com/b0ab025e74b0a0b3b8d7781e53f3f728","width":"1080","height":"2580"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853477115","isVote":1,"tweetType":1,"viewCount":2423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":825988159,"gmtCreate":1634190293162,"gmtModify":1634190293162,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"What about vaccine&nbsp;stocks...they are a little worrisome now with its constant yoyo prices?","listText":"What about vaccine&nbsp;stocks...they are a little worrisome now with its constant yoyo prices?","text":"What about vaccine stocks...they are a little worrisome now with its constant yoyo prices?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/825988159","repostId":"1111412750","repostType":4,"repost":{"id":"1111412750","kind":"news","pubTimestamp":1634182832,"share":"https://www.laohu8.com/m/news/1111412750?lang=zh_CN&edition=full","pubTime":"2021-10-14 11:40","market":"us","language":"en","title":"Buying The Dip Is Dead<blockquote>逢低买入已死</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1111412750","media":"seekingalpha","summary":"Summary\n\nBuying the dip died when the volatility sellers failed to show up.\nThere's a mechanical rea","content":"<p>Summary</p><p><blockquote>总结</blockquote></p><p> <ul>  <li>Buying the dip died when the volatility sellers failed to show up.</li>  <li>There's a mechanical reason why the market has not \"bounced back.\"</li>  <li>That mechanical reason has broken down due to fundamental shifts.</li> </ul> The market has been melting, and that \"buy the dip\" mentality seems to be in trouble. There's an excellent reason for why buying the dip hasn't worked, and probably why it won't work this time around either. All you have to do is look at the VIX and the SKEW indexes to understand why.</p><p><blockquote><ul><li>当波动性卖家未能出现时，逢低买入就死了。</li><li>市场没有“反弹”有一个机械原因。</li><li>由于根本性的转变，这种机械原因已经被打破。</li></ul>市场一直在融化，那种“逢低买入”的心态似乎遇到了麻烦。有一个很好的理由解释为什么逢低买入没有奏效，而且可能这次也不会奏效。你所要做的就是看看VIX和偏斜指数，就能明白为什么。</blockquote></p><p> Falling volatility has been a lynchpin of propping up the market every time it falters since the COVID low. Every time the market sank, the VIX would spike higher. Then, a swarm of traders would come in looking to short volatility, which would send the VIX lower, pushing the S&amp;P 500 higher. However, that component of the market appears to be gone. The VIX has been steadily rising since June, with higher lows. More recently, the VIX hasn't been able to get below 18, and each drop in the S&amp;P 500 has seen lower highs.</p><p><blockquote>自新冠疫情低点以来，波动性下降一直是支撑市场每次出现动摇的关键。每次市场下跌，VIX都会飙升。然后，一群交易者会进来寻求做空波动性，这将导致VIX走低，推高标普500。然而，市场的这一部分似乎已经消失了。VIX自6月以来一直稳步上升，低点较高。最近，VIX未能跌破18，标普500的每次下跌都会出现较低的高点。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7d40186560f397cc6ebdc4e85ba18725\" tg-width=\"640\" tg-height=\"397\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Additionally, the SKEW index has cratered in recent weeks. It's because traders that have been betting on volatility falling have likely been shorting at-the-money forms of it, and to hedge those positions, they have been buying out-of-money forms. It's why the SKEW index reached record highs in June as the VIX hit its lows.</p><p><blockquote>此外，偏斜指数最近几周有所下降。这是因为一直押注波动性下降的交易者可能一直在做空平价形式的波动性，为了对冲这些头寸，他们一直在买入价外形式的波动性。这就是为什么SKEW指数在6月份创下历史新高，而VIX则触及低点。</blockquote></p><p> The SKEW index wasn't rising into June 2021 because traders were trying to hedge against tail risk or an unforeseen event. The SKEW index was rising as a hedge against short volatility positions.</p><p><blockquote>SKEW指数在2021年6月没有上升，因为交易者试图对冲尾部风险或不可预见的事件。作为对波动性空头头寸的对冲，SKEW指数正在上升。</blockquote></p><p> If volatility sellers do not return to this market, then a big piece of why the market always has been able to bounce back so quickly on every dip will be gone. Buying the dip will simply not work.</p><p><blockquote>如果波动性卖家不重返这个市场，那么为什么市场总是能够在每次下跌时如此迅速地反弹的很大一部分将消失。逢低买入根本行不通。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d92c33e67c289d5c9d1e8d0d6ec74b5d\" tg-width=\"640\" tg-height=\"397\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> But with QE likely on its way out, financial conditions are likely to tighten as a result. It seems that volatility sellers have gone missing for a good reason. If that's the case, the considerable risk in the market isn't going to be the fear of missing out. The substantial risk is a meltdown, not all that&nbsp;dissimilar to that of 2018, which I have noted on several occasions many of the same similarities of today to back then.</p><p><blockquote>但随着量化宽松可能退出，金融状况可能会因此收紧。波动性卖家的消失似乎是有充分理由的。如果是这样的话，市场上相当大的风险就不会是害怕错过了。实质性的风险是崩溃，与2018年没有太大不同，我在几个场合注意到今天与当时有许多相似之处。</blockquote></p><p> The dollar index may be a big piece of that. It has been surging higher, and that the S&amp;P 500 has been trading precisely the opposite to the dollar's move. When the dollar has been strengthening, the S&amp;P 500 has been falling and vice versa. The&nbsp;dollar is telling us that tapering&nbsp;is coming and very soon. The stock market knows what this means too, and it isn't good for stocks.</p><p><blockquote>美元指数可能是其中很大一部分。它一直在飙升，而标普500的交易与美元的走势完全相反。当美元一直走强时，标普500一直在下跌，反之亦然。美元告诉我们，缩减规模即将到来，而且很快就会到来。股市也知道这意味着什么，这对股市不利。</blockquote></p><p> The two-year Treasury rate has also been creeping higher and now stands at more than 35 bps. The two-year most likely needs to rise much more if the Fed is tapering. By the time the QE taper ended in October 2014, the two-year was around 50 to 60 bps. That means the&nbsp;two-year&nbsp;now has further to climb as this process commences potentially as soon as the November FOMC meeting.</p><p><blockquote>两年期国债利率也一直在攀升，目前已超过35个基点。如果美联储缩减规模，两年期国债很可能需要上涨更多。到2014年10月QE缩减结束时，两年期利率约为50至60个基点。这意味着两年期利率现在必须进一步攀升，因为这一过程可能会在11月FOMC会议上开始。</blockquote></p><p> Despite the stronger dollar, the 10-year has been falling, and that's because the market is picking up on what I have been telling you for months. Growth rates here in the US and around the globe have been slowing and are now near stall speed. They have gotten so slow here in the US that the Atlanta Fed GDPNow is now projecting just a 1.3% third quarter growth rate, an enormous drop from the second-quarter reading of 6.7%.</p><p><blockquote>尽管美元走强，但10年期国债一直在下跌，这是因为市场正在接受我几个月来一直告诉你的内容。美国和全球的增长率一直在放缓，现在接近失速速度。美国的增长速度如此缓慢，以至于亚特兰大联储GDPNow目前预计第三季度增长率仅为1.3%，较第二季度的6.7%大幅下降。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ce210603773584da38e4fbf054f31ba9\" tg-width=\"640\" tg-height=\"480\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The market knows that a strong dollar in regular times exports inflationary forces aboard in countries that buy commodities, finances debt, or conduct business in dollars. It's a global growth killer. On top of that, rising prices for things like energy are already likely to slow growth, and now with the dollar rising, it makes the problem even more prominent. It is driving the rates on the long-end of the curve lower and flattening the yield curve.</p><p><blockquote>市场知道，在正常时期，强势美元会向购买大宗商品、为债务融资或以美元开展业务的国家输出通胀力量。这是全球增长杀手。最重要的是，能源等价格上涨已经可能会减缓经济增长，现在随着美元升值，这使得问题更加突出。它正在压低曲线长端的利率并使收益率曲线变平。</blockquote></p><p> This time is different from previous pullbacks. This is why this time the pullback is only in its early phases. Earnings estimates have started to come down, and they are likely to come down further because if one thing is crystal clear, GDP growth expectations were way off base, and means that it is highly likely that&nbsp;earnings estimates&nbsp;are way off base, which means earnings growth rates will be heading lower or top of what they have declined.</p><p><blockquote>这次不同于以往的回调。这就是为什么这次回调只是处于早期阶段。盈利预期已经开始下降，而且可能会进一步下降，因为如果有一件事非常清楚，那就是GDP增长预期远远偏离基础，这意味着盈利预期很可能远远偏离基础，这意味着盈利增长率将下降或超过下降水平。</blockquote></p><p></p><p> <img src=\"https://static.tigerbbs.com/b784f4142c7b91a6c36b4c8d263db047\" tg-width=\"640\" tg-height=\"480\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> It's just a matter of when the stock market realizes that a Fed tapering event will push the dollar index even higher at the worst possible time resulting in a massive global growth scare. Perhaps the biggest reason why the volatility sellers have left the building.</p><p><blockquote>这只是股市何时意识到美联储缩减规模事件将在最糟糕的时候推高美元指数，从而导致大规模的全球增长恐慌的问题。也许这是波动性卖家离开大楼的最大原因。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buying The Dip Is Dead<blockquote>逢低买入已死</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuying The Dip Is Dead<blockquote>逢低买入已死</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2021-10-14 11:40</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Summary</p><p><blockquote>总结</blockquote></p><p> <ul>  <li>Buying the dip died when the volatility sellers failed to show up.</li>  <li>There's a mechanical reason why the market has not \"bounced back.\"</li>  <li>That mechanical reason has broken down due to fundamental shifts.</li> </ul> The market has been melting, and that \"buy the dip\" mentality seems to be in trouble. There's an excellent reason for why buying the dip hasn't worked, and probably why it won't work this time around either. All you have to do is look at the VIX and the SKEW indexes to understand why.</p><p><blockquote><ul><li>当波动性卖家未能出现时，逢低买入就死了。</li><li>市场没有“反弹”有一个机械原因。</li><li>由于根本性的转变，这种机械原因已经被打破。</li></ul>市场一直在融化，那种“逢低买入”的心态似乎遇到了麻烦。有一个很好的理由解释为什么逢低买入没有奏效，而且可能这次也不会奏效。你所要做的就是看看VIX和偏斜指数，就能明白为什么。</blockquote></p><p> Falling volatility has been a lynchpin of propping up the market every time it falters since the COVID low. Every time the market sank, the VIX would spike higher. Then, a swarm of traders would come in looking to short volatility, which would send the VIX lower, pushing the S&amp;P 500 higher. However, that component of the market appears to be gone. The VIX has been steadily rising since June, with higher lows. More recently, the VIX hasn't been able to get below 18, and each drop in the S&amp;P 500 has seen lower highs.</p><p><blockquote>自新冠疫情低点以来，波动性下降一直是支撑市场每次出现动摇的关键。每次市场下跌，VIX都会飙升。然后，一群交易者会进来寻求做空波动性，这将导致VIX走低，推高标普500。然而，市场的这一部分似乎已经消失了。VIX自6月以来一直稳步上升，低点较高。最近，VIX未能跌破18，标普500的每次下跌都会出现较低的高点。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7d40186560f397cc6ebdc4e85ba18725\" tg-width=\"640\" tg-height=\"397\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Additionally, the SKEW index has cratered in recent weeks. It's because traders that have been betting on volatility falling have likely been shorting at-the-money forms of it, and to hedge those positions, they have been buying out-of-money forms. It's why the SKEW index reached record highs in June as the VIX hit its lows.</p><p><blockquote>此外，偏斜指数最近几周有所下降。这是因为一直押注波动性下降的交易者可能一直在做空平价形式的波动性，为了对冲这些头寸，他们一直在买入价外形式的波动性。这就是为什么SKEW指数在6月份创下历史新高，而VIX则触及低点。</blockquote></p><p> The SKEW index wasn't rising into June 2021 because traders were trying to hedge against tail risk or an unforeseen event. The SKEW index was rising as a hedge against short volatility positions.</p><p><blockquote>SKEW指数在2021年6月没有上升，因为交易者试图对冲尾部风险或不可预见的事件。作为对波动性空头头寸的对冲，SKEW指数正在上升。</blockquote></p><p> If volatility sellers do not return to this market, then a big piece of why the market always has been able to bounce back so quickly on every dip will be gone. Buying the dip will simply not work.</p><p><blockquote>如果波动性卖家不重返这个市场，那么为什么市场总是能够在每次下跌时如此迅速地反弹的很大一部分将消失。逢低买入根本行不通。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d92c33e67c289d5c9d1e8d0d6ec74b5d\" tg-width=\"640\" tg-height=\"397\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> But with QE likely on its way out, financial conditions are likely to tighten as a result. It seems that volatility sellers have gone missing for a good reason. If that's the case, the considerable risk in the market isn't going to be the fear of missing out. The substantial risk is a meltdown, not all that&nbsp;dissimilar to that of 2018, which I have noted on several occasions many of the same similarities of today to back then.</p><p><blockquote>但随着量化宽松可能退出，金融状况可能会因此收紧。波动性卖家的消失似乎是有充分理由的。如果是这样的话，市场上相当大的风险就不会是害怕错过了。实质性的风险是崩溃，与2018年没有太大不同，我在几个场合注意到今天与当时有许多相似之处。</blockquote></p><p> The dollar index may be a big piece of that. It has been surging higher, and that the S&amp;P 500 has been trading precisely the opposite to the dollar's move. When the dollar has been strengthening, the S&amp;P 500 has been falling and vice versa. The&nbsp;dollar is telling us that tapering&nbsp;is coming and very soon. The stock market knows what this means too, and it isn't good for stocks.</p><p><blockquote>美元指数可能是其中很大一部分。它一直在飙升，而标普500的交易与美元的走势完全相反。当美元一直走强时，标普500一直在下跌，反之亦然。美元告诉我们，缩减规模即将到来，而且很快就会到来。股市也知道这意味着什么，这对股市不利。</blockquote></p><p> The two-year Treasury rate has also been creeping higher and now stands at more than 35 bps. The two-year most likely needs to rise much more if the Fed is tapering. By the time the QE taper ended in October 2014, the two-year was around 50 to 60 bps. That means the&nbsp;two-year&nbsp;now has further to climb as this process commences potentially as soon as the November FOMC meeting.</p><p><blockquote>两年期国债利率也一直在攀升，目前已超过35个基点。如果美联储缩减规模，两年期国债很可能需要上涨更多。到2014年10月QE缩减结束时，两年期利率约为50至60个基点。这意味着两年期利率现在必须进一步攀升，因为这一过程可能会在11月FOMC会议上开始。</blockquote></p><p> Despite the stronger dollar, the 10-year has been falling, and that's because the market is picking up on what I have been telling you for months. Growth rates here in the US and around the globe have been slowing and are now near stall speed. They have gotten so slow here in the US that the Atlanta Fed GDPNow is now projecting just a 1.3% third quarter growth rate, an enormous drop from the second-quarter reading of 6.7%.</p><p><blockquote>尽管美元走强，但10年期国债一直在下跌，这是因为市场正在接受我几个月来一直告诉你的内容。美国和全球的增长率一直在放缓，现在接近失速速度。美国的增长速度如此缓慢，以至于亚特兰大联储GDPNow目前预计第三季度增长率仅为1.3%，较第二季度的6.7%大幅下降。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ce210603773584da38e4fbf054f31ba9\" tg-width=\"640\" tg-height=\"480\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> The market knows that a strong dollar in regular times exports inflationary forces aboard in countries that buy commodities, finances debt, or conduct business in dollars. It's a global growth killer. On top of that, rising prices for things like energy are already likely to slow growth, and now with the dollar rising, it makes the problem even more prominent. It is driving the rates on the long-end of the curve lower and flattening the yield curve.</p><p><blockquote>市场知道，在正常时期，强势美元会向购买大宗商品、为债务融资或以美元开展业务的国家输出通胀力量。这是全球增长杀手。最重要的是，能源等价格上涨已经可能会减缓经济增长，现在随着美元升值，这使得问题更加突出。它正在压低曲线长端的利率并使收益率曲线变平。</blockquote></p><p> This time is different from previous pullbacks. This is why this time the pullback is only in its early phases. Earnings estimates have started to come down, and they are likely to come down further because if one thing is crystal clear, GDP growth expectations were way off base, and means that it is highly likely that&nbsp;earnings estimates&nbsp;are way off base, which means earnings growth rates will be heading lower or top of what they have declined.</p><p><blockquote>这次不同于以往的回调。这就是为什么这次回调只是处于早期阶段。盈利预期已经开始下降，而且可能会进一步下降，因为如果有一件事非常清楚，那就是GDP增长预期远远偏离基础，这意味着盈利预期很可能远远偏离基础，这意味着盈利增长率将下降或超过下降水平。</blockquote></p><p></p><p> <img src=\"https://static.tigerbbs.com/b784f4142c7b91a6c36b4c8d263db047\" tg-width=\"640\" tg-height=\"480\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> It's just a matter of when the stock market realizes that a Fed tapering event will push the dollar index even higher at the worst possible time resulting in a massive global growth scare. Perhaps the biggest reason why the volatility sellers have left the building.</p><p><blockquote>这只是股市何时意识到美联储缩减规模事件将在最糟糕的时候推高美元指数，从而导致大规模的全球增长恐慌的问题。也许这是波动性卖家离开大楼的最大原因。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4459696-buying-the-dip-is-dead\">seekingalpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://seekingalpha.com/article/4459696-buying-the-dip-is-dead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111412750","content_text":"Summary\n\nBuying the dip died when the volatility sellers failed to show up.\nThere's a mechanical reason why the market has not \"bounced back.\"\nThat mechanical reason has broken down due to fundamental shifts.\n\nThe market has been melting, and that \"buy the dip\" mentality seems to be in trouble. There's an excellent reason for why buying the dip hasn't worked, and probably why it won't work this time around either. All you have to do is look at the VIX and the SKEW indexes to understand why.\nFalling volatility has been a lynchpin of propping up the market every time it falters since the COVID low. Every time the market sank, the VIX would spike higher. Then, a swarm of traders would come in looking to short volatility, which would send the VIX lower, pushing the S&P 500 higher. However, that component of the market appears to be gone. The VIX has been steadily rising since June, with higher lows. More recently, the VIX hasn't been able to get below 18, and each drop in the S&P 500 has seen lower highs.\n\nAdditionally, the SKEW index has cratered in recent weeks. It's because traders that have been betting on volatility falling have likely been shorting at-the-money forms of it, and to hedge those positions, they have been buying out-of-money forms. It's why the SKEW index reached record highs in June as the VIX hit its lows.\nThe SKEW index wasn't rising into June 2021 because traders were trying to hedge against tail risk or an unforeseen event. The SKEW index was rising as a hedge against short volatility positions.\nIf volatility sellers do not return to this market, then a big piece of why the market always has been able to bounce back so quickly on every dip will be gone. Buying the dip will simply not work.\n\nBut with QE likely on its way out, financial conditions are likely to tighten as a result. It seems that volatility sellers have gone missing for a good reason. If that's the case, the considerable risk in the market isn't going to be the fear of missing out. The substantial risk is a meltdown, not all that dissimilar to that of 2018, which I have noted on several occasions many of the same similarities of today to back then.\nThe dollar index may be a big piece of that. It has been surging higher, and that the S&P 500 has been trading precisely the opposite to the dollar's move. When the dollar has been strengthening, the S&P 500 has been falling and vice versa. The dollar is telling us that tapering is coming and very soon. The stock market knows what this means too, and it isn't good for stocks.\nThe two-year Treasury rate has also been creeping higher and now stands at more than 35 bps. The two-year most likely needs to rise much more if the Fed is tapering. By the time the QE taper ended in October 2014, the two-year was around 50 to 60 bps. That means the two-year now has further to climb as this process commences potentially as soon as the November FOMC meeting.\nDespite the stronger dollar, the 10-year has been falling, and that's because the market is picking up on what I have been telling you for months. Growth rates here in the US and around the globe have been slowing and are now near stall speed. They have gotten so slow here in the US that the Atlanta Fed GDPNow is now projecting just a 1.3% third quarter growth rate, an enormous drop from the second-quarter reading of 6.7%.\n\nThe market knows that a strong dollar in regular times exports inflationary forces aboard in countries that buy commodities, finances debt, or conduct business in dollars. It's a global growth killer. On top of that, rising prices for things like energy are already likely to slow growth, and now with the dollar rising, it makes the problem even more prominent. It is driving the rates on the long-end of the curve lower and flattening the yield curve.\nThis time is different from previous pullbacks. This is why this time the pullback is only in its early phases. Earnings estimates have started to come down, and they are likely to come down further because if one thing is crystal clear, GDP growth expectations were way off base, and means that it is highly likely that earnings estimates are way off base, which means earnings growth rates will be heading lower or top of what they have declined.\n\nIt's just a matter of when the stock market realizes that a Fed tapering event will push the dollar index even higher at the worst possible time resulting in a massive global growth scare. Perhaps the biggest reason why the volatility sellers have left the building.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3627,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828104978,"gmtCreate":1633856750164,"gmtModify":1633856750274,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Let's hope for the best soon!","listText":"Let's hope for the best soon!","text":"Let's hope for the best soon!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/828104978","repostId":"1194780749","repostType":4,"isVote":1,"tweetType":1,"viewCount":2267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823582118,"gmtCreate":1633649377190,"gmtModify":1633649377382,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Hopefully more bullish run tonight.","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Hopefully more bullish run tonight.","text":"$Apple(AAPL)$Hopefully more bullish run tonight.","images":[{"img":"https://static.tigerbbs.com/301856a045b0599f0b01bd045eab71b3","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823582118","isVote":1,"tweetType":1,"viewCount":1386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864685023,"gmtCreate":1633097856622,"gmtModify":1633097856762,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Is this why...for BioNTech investors = Negative news?","listText":"Is this why...for BioNTech investors = Negative news?","text":"Is this why...for BioNTech investors = Negative news?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864685023","repostId":"2172968435","repostType":4,"isVote":1,"tweetType":1,"viewCount":3136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864152478,"gmtCreate":1633077746370,"gmtModify":1633077746546,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>It's like I see no hope at all...manage to average down but the price plummet even further today.","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>It's like I see no hope at all...manage to average down but the price plummet even further today.","text":"$BioNTech SE(BNTX)$It's like I see no hope at all...manage to average down but the price plummet even further today.","images":[{"img":"https://static.tigerbbs.com/27332c301aa7b18209f2e41ac46cd4ce","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864152478","isVote":1,"tweetType":1,"viewCount":3299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862331592,"gmtCreate":1632836859315,"gmtModify":1632836859416,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>time to faint???","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>time to faint???","text":"$BioNTech SE(BNTX)$time to faint???","images":[{"img":"https://static.tigerbbs.com/b1b5ef580293b62713f8ef5516808ee5","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/862331592","isVote":1,"tweetType":1,"viewCount":1416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":861423870,"gmtCreate":1632532705290,"gmtModify":1632710797285,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Why is the stock price always disappointing, past its&nbsp;heyday? Holding on is so draining...&nbsp;","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Why is the stock price always disappointing, past its&nbsp;heyday? Holding on is so draining...&nbsp;","text":"$BioNTech SE(BNTX)$Why is the stock price always disappointing, past its heyday? Holding on is so draining...","images":[{"img":"https://static.tigerbbs.com/a4a44486163cb336e20188132c1bb559","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/861423870","isVote":1,"tweetType":1,"viewCount":527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":869739702,"gmtCreate":1632320972306,"gmtModify":1632801246242,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Happy!","listText":"Happy!","text":"Happy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/869739702","repostId":"1143821004","repostType":4,"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860812520,"gmtCreate":1632151534160,"gmtModify":1632802473186,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Just dipped to my buying price...is this gonna stay like that for the next few days...or weeks...?","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Just dipped to my buying price...is this gonna stay like that for the next few days...or weeks...?","text":"$Apple(AAPL)$Just dipped to my buying price...is this gonna stay like that for the next few days...or weeks...?","images":[{"img":"https://static.tigerbbs.com/b0af89bb1574b432e8444f3f77f33d8f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860812520","isVote":1,"tweetType":1,"viewCount":607,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":818774678,"gmtCreate":1630453360694,"gmtModify":1631891607506,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Am in the same boat as you. Bought at $452, average down $392...and have an almost heart attack to see it drop to $329 now...","listText":"Am in the same boat as you. Bought at $452, average down $392...and have an almost heart attack to see it drop to $329 now...","text":"Am in the same boat as you. Bought at $452, average down $392...and have an almost heart attack to see it drop to $329 now...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/818774678","repostId":"818716571","repostType":1,"repost":{"id":818716571,"gmtCreate":1630449630993,"gmtModify":1631883797747,"author":{"id":"3552874562834581","authorId":"3552874562834581","name":"Kel1","avatar":"https://static.tigerbbs.com/85967b7114ebaa24185158560185f10b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3552874562834581","idStr":"3552874562834581"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Will this recover?","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Will this recover?","text":"$BioNTech SE(BNTX)$Will this recover?","images":[{"img":"https://static.tigerbbs.com/05a1cc87ba51e480f080e8ee03874f6d","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818716571","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":725,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811408639,"gmtCreate":1630334341921,"gmtModify":1704958704461,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Could it go up to $159?/$160 mark? 😍","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Could it go up to $159?/$160 mark? 😍","text":"$Apple(AAPL)$Could it go up to $159?/$160 mark? 😍","images":[{"img":"https://static.tigerbbs.com/4598427e97b0516704e776ad6ac92d5c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/811408639","isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":835555011,"gmtCreate":1629728460633,"gmtModify":1631891607533,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Hopefully it will rise to about its pre-glory price of $480+?","listText":"Hopefully it will rise to about its pre-glory price of $480+?","text":"Hopefully it will rise to about its pre-glory price of $480+?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/835555011","repostId":"1189910879","repostType":4,"isVote":1,"tweetType":1,"viewCount":525,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839819716,"gmtCreate":1629138426235,"gmtModify":1631891607546,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>will it go to $160? To hold or sell?","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>will it go to $160? To hold or sell?","text":"$Apple(AAPL)$will it go to $160? To hold or sell?","images":[{"img":"https://static.tigerbbs.com/d28cd1e227e2939062a78ffd74a079f3","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/839819716","isVote":1,"tweetType":1,"viewCount":618,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":839321095,"gmtCreate":1629123032917,"gmtModify":1631883798019,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>what is happening? Why was it doing well last week and today opening mkt and it sink so bad?","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>what is happening? Why was it doing well last week and today opening mkt and it sink so bad?","text":"$BioNTech SE(BNTX)$what is happening? Why was it doing well last week and today opening mkt and it sink so bad?","images":[{"img":"https://static.tigerbbs.com/f48fe970fb82f2b25a061d030b7565cb","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":78,"commentSize":27,"repostSize":1,"link":"https://laohu8.com/post/839321095","isVote":1,"tweetType":1,"viewCount":6370,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"262190804341046","authorId":"262190804341046","name":"Jason1205","avatar":"https://static.tigerbbs.com/a22c3af3bb938bf74c151660df1d68dd","crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"262190804341046","idStr":"262190804341046"},"content":"because of Afghanistan?","text":"because of Afghanistan?","html":"because of Afghanistan?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":897013387,"gmtCreate":1628862601349,"gmtModify":1631891607556,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Things are certainly looking up! Would it ever hit close to Moderna like days before, closing nearly to 500?","listText":"Things are certainly looking up! Would it ever hit close to Moderna like days before, closing nearly to 500?","text":"Things are certainly looking up! Would it ever hit close to Moderna like days before, closing nearly to 500?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897013387","repostId":"1141206470","repostType":4,"repost":{"id":"1141206470","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628861824,"share":"https://www.laohu8.com/m/news/1141206470?lang=zh_CN&edition=full","pubTime":"2021-08-13 21:37","market":"us","language":"en","title":"BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity<blockquote>BioNTech和Moderna因同意为免疫力较弱的人提供增强剂而股价上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141206470","media":"Tiger Newspress","summary":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster ","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stocks were up in&nbsp;early&nbsp;trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p><p><blockquote>在FDA授权为免疫力较弱的人注射Covid-19加强疫苗后，BioNTech和Moderna的股票在早盘交易中上涨。</blockquote></p><p> BioNTech was up 3% and Moderna gained 3%, while Pfizer&nbsp;, which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p><p><blockquote>BioNTech上涨3%，Moderna上涨3%，而与BioNTech联合开发两剂mRNA疫苗的辉瑞上涨2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Late on Thursday, the U.S. Food and Drug Administration&nbsp;authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p><p><blockquote>周四晚间，美国。美国食品药品监督管理局批准了辉瑞公司（PFE）的加强剂量疫苗。N）和Moderna公司（MRNA.O）用于免疫系统受损的人。</blockquote></p><p> Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p><p><blockquote>辉瑞及其德国合作伙伴BioNTech和Moderna仅在2021年和2022年就锁定了超过600亿美元的疫苗销售额。这些协议包括向富裕国家提供前两剂疫苗以及数十亿美元的潜在加强剂。</blockquote></p><p> Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p><p><blockquote>展望未来，分析师预测辉瑞/BioNTech疫苗的收入将超过66亿美元，Moderna的收入将超过76亿美元，其中大部分来自助推器销售。他们最终看到年度市场稳定在50亿美元左右或更高，更多的制药商将争夺这些销售额。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity<blockquote>BioNTech和Moderna因同意为免疫力较弱的人提供增强剂而股价上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity<blockquote>BioNTech和Moderna因同意为免疫力较弱的人提供增强剂而股价上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-13 21:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stocks were up in&nbsp;early&nbsp;trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.</p><p><blockquote>在FDA授权为免疫力较弱的人注射Covid-19加强疫苗后，BioNTech和Moderna的股票在早盘交易中上涨。</blockquote></p><p> BioNTech was up 3% and Moderna gained 3%, while Pfizer&nbsp;, which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.</p><p><blockquote>BioNTech上涨3%，Moderna上涨3%，而与BioNTech联合开发两剂mRNA疫苗的辉瑞上涨2%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/18d1d9877f2ba36a61eaf23f41b8914f\" tg-width=\"898\" tg-height=\"607\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Late on Thursday, the U.S. Food and Drug Administration&nbsp;authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.</p><p><blockquote>周四晚间，美国。美国食品药品监督管理局批准了辉瑞公司（PFE）的加强剂量疫苗。N）和Moderna公司（MRNA.O）用于免疫系统受损的人。</blockquote></p><p> Pfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.</p><p><blockquote>辉瑞及其德国合作伙伴BioNTech和Moderna仅在2021年和2022年就锁定了超过600亿美元的疫苗销售额。这些协议包括向富裕国家提供前两剂疫苗以及数十亿美元的潜在加强剂。</blockquote></p><p> Going forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.</p><p><blockquote>展望未来，分析师预测辉瑞/BioNTech疫苗的收入将超过66亿美元，Moderna的收入将超过76亿美元，其中大部分来自助推器销售。他们最终看到年度市场稳定在50亿美元左右或更高，更多的制药商将争夺这些销售额。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141206470","content_text":"BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster shots for people with weak immunity.\nBioNTech was up 3% and Moderna gained 3%, while Pfizer , which has jointly developed the two-dose mRNA vaccine with BioNTech, was up 2%.\n\nLate on Thursday, the U.S. Food and Drug Administration authorized a booster doseof vaccines from Pfizer Inc(PFE.N)and Moderna Inc(MRNA.O)for people with compromised immune systems.\nPfizer, along with its German partner BioNTech , and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. The agreements include supply of the initial two doses of their vaccines as well as billions of dollars in potential boosters for wealthy nations.\nGoing forward, analysts have forecast revenue of over $6.6 billion for the Pfizer/BioNTech shot and $7.6 billion for Moderna in 2023, mostly from booster sales. They eventually see the annual market settling at around $5 billion or higher, with additional drugmakers competing for those sales.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":839321095,"gmtCreate":1629123032917,"gmtModify":1631883798019,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>what is happening? Why was it doing well last week and today opening mkt and it sink so bad?","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>what is happening? Why was it doing well last week and today opening mkt and it sink so bad?","text":"$BioNTech SE(BNTX)$what is happening? Why was it doing well last week and today opening mkt and it sink so bad?","images":[{"img":"https://static.tigerbbs.com/f48fe970fb82f2b25a061d030b7565cb","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":78,"commentSize":27,"repostSize":1,"link":"https://laohu8.com/post/839321095","isVote":1,"tweetType":1,"viewCount":6370,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"262190804341046","authorId":"262190804341046","name":"Jason1205","avatar":"https://static.tigerbbs.com/a22c3af3bb938bf74c151660df1d68dd","crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"262190804341046","idStr":"262190804341046"},"content":"because of Afghanistan?","text":"because of Afghanistan?","html":"because of Afghanistan?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":808478047,"gmtCreate":1627608292589,"gmtModify":1631886148830,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>OMG! SOMEONE PLEASE TELL me this stock will soar soon and not plummet further...to sell or not to sell now?","listText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>OMG! SOMEONE PLEASE TELL me this stock will soar soon and not plummet further...to sell or not to sell now?","text":"$Pinterest, Inc.(PINS)$OMG! SOMEONE PLEASE TELL me this stock will soar soon and not plummet further...to sell or not to sell now?","images":[{"img":"https://static.tigerbbs.com/d3f4c62fda66a6d444a2407e7ba7c2c7","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/808478047","isVote":1,"tweetType":1,"viewCount":1585,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":862331592,"gmtCreate":1632836859315,"gmtModify":1632836859416,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>time to faint???","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>time to faint???","text":"$BioNTech SE(BNTX)$time to faint???","images":[{"img":"https://static.tigerbbs.com/b1b5ef580293b62713f8ef5516808ee5","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/862331592","isVote":1,"tweetType":1,"viewCount":1416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":870746623,"gmtCreate":1636655711171,"gmtModify":1636655711386,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Seriously? Why is this tanking when more vaccines are needed now for 3rd booster shots as well as for 5 - 11yo? Frustrating...😑","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Seriously? Why is this tanking when more vaccines are needed now for 3rd booster shots as well as for 5 - 11yo? Frustrating...😑","text":"$BioNTech SE(BNTX)$Seriously? Why is this tanking when more vaccines are needed now for 3rd booster shots as well as for 5 - 11yo? Frustrating...😑","images":[{"img":"https://static.tigerbbs.com/7023799f8e65f048e38dc8f783b6a876","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/870746623","isVote":1,"tweetType":1,"viewCount":2451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":894097920,"gmtCreate":1628776934260,"gmtModify":1631891607569,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Fantastic positive&nbsp; news! Keeping fingers crossed!","listText":"Fantastic positive&nbsp; news! Keeping fingers crossed!","text":"Fantastic positive news! Keeping fingers crossed!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894097920","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=zh_CN&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p><p><blockquote>BioNTech和Moderna股价周四早盘上涨，有望收复前一交易日的部分跌幅，此前《华尔街日报》报道称FDA可能授权为免疫功能低下的人注射Covid-19加强针。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p><p><blockquote>BioNTech和Moderna在前一交易日分别暴跌14%和15.6%后上涨3.96%和2%。辉瑞(NYSE：PFE)周三下跌4%，现上涨1%。</blockquote></p><p> The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p><p><blockquote>《华尔街日报》报道称，由于德尔塔变异毒株的快速传播，新冠病例激增，美国食品和药物管理局即将决定授权为免疫力较弱的人进行加强注射。</blockquote></p><p> There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p><p><blockquote>越来越多的证据表明，对于免疫力低下的人来说，两针疫苗是不够的。疫苗制造商计划在本月或下个月向FDA申请加强注射的批准。</blockquote></p><p> BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p><p><blockquote>BioNTech、Moderna和辉瑞周三均收低，此前有消息称，欧洲药品监管机构正在研究少数人在接种Covid-19疫苗后报告的三种新病症，以评估它们是否可能是副作用。</blockquote></p><p> The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p><p><blockquote>据报道，服用Moderna或BioNTech-Pfizer生产的mRNA疫苗的患者出现了这种情况。</blockquote></p><p> Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p><p><blockquote>辉瑞和BioNTech正在合作研究和营销他们的新冠肺炎疫苗。疫苗的费用和利润由辉瑞和BioNTech平分。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster<blockquote>BioNTech和Moderna因FDA可能批准增强剂的报道而上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-12 21:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p><p><blockquote>BioNTech和Moderna股价周四早盘上涨，有望收复前一交易日的部分跌幅，此前《华尔街日报》报道称FDA可能授权为免疫功能低下的人注射Covid-19加强针。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p><p><blockquote>BioNTech和Moderna在前一交易日分别暴跌14%和15.6%后上涨3.96%和2%。辉瑞(NYSE：PFE)周三下跌4%，现上涨1%。</blockquote></p><p> The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p><p><blockquote>《华尔街日报》报道称，由于德尔塔变异毒株的快速传播，新冠病例激增，美国食品和药物管理局即将决定授权为免疫力较弱的人进行加强注射。</blockquote></p><p> There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p><p><blockquote>越来越多的证据表明，对于免疫力低下的人来说，两针疫苗是不够的。疫苗制造商计划在本月或下个月向FDA申请加强注射的批准。</blockquote></p><p> BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p><p><blockquote>BioNTech、Moderna和辉瑞周三均收低，此前有消息称，欧洲药品监管机构正在研究少数人在接种Covid-19疫苗后报告的三种新病症，以评估它们是否可能是副作用。</blockquote></p><p> The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p><p><blockquote>据报道，服用Moderna或BioNTech-Pfizer生产的mRNA疫苗的患者出现了这种情况。</blockquote></p><p> Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p><p><blockquote>辉瑞和BioNTech正在合作研究和营销他们的新冠肺炎疫苗。疫苗的费用和利润由辉瑞和BioNTech平分。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801200884,"gmtCreate":1627517023748,"gmtModify":1631884033764,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/LMND\">$Lemonade, Inc.(LMND)$</a>sigh...any chance of a lift-up?&nbsp;","listText":"<a href=\"https://laohu8.com/S/LMND\">$Lemonade, Inc.(LMND)$</a>sigh...any chance of a lift-up?&nbsp;","text":"$Lemonade, Inc.(LMND)$sigh...any chance of a lift-up?","images":[{"img":"https://static.tigerbbs.com/74964a2fe535cbfb8cc997e1bd52365d","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/801200884","isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":155359063,"gmtCreate":1625379288252,"gmtModify":1633941075727,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Good article, thanks!","listText":"Good article, thanks!","text":"Good article, thanks!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/155359063","repostId":"1160702483","repostType":4,"isVote":1,"tweetType":1,"viewCount":190,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860812520,"gmtCreate":1632151534160,"gmtModify":1632802473186,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Just dipped to my buying price...is this gonna stay like that for the next few days...or weeks...?","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Just dipped to my buying price...is this gonna stay like that for the next few days...or weeks...?","text":"$Apple(AAPL)$Just dipped to my buying price...is this gonna stay like that for the next few days...or weeks...?","images":[{"img":"https://static.tigerbbs.com/b0af89bb1574b432e8444f3f77f33d8f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860812520","isVote":1,"tweetType":1,"viewCount":607,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":811408639,"gmtCreate":1630334341921,"gmtModify":1704958704461,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Could it go up to $159?/$160 mark? 😍","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Could it go up to $159?/$160 mark? 😍","text":"$Apple(AAPL)$Could it go up to $159?/$160 mark? 😍","images":[{"img":"https://static.tigerbbs.com/4598427e97b0516704e776ad6ac92d5c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/811408639","isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":846771824,"gmtCreate":1636118254704,"gmtModify":1636118931968,"author":{"id":"4087475573507020","authorId":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087475573507020","idStr":"4087475573507020"},"themes":[],"title":"","htmlText":"Wth...","listText":"Wth...","text":"Wth...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846771824","repostId":"1196545101","repostType":2,"repost":{"id":"1196545101","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636114848,"share":"https://www.laohu8.com/m/news/1196545101?lang=zh_CN&edition=full","pubTime":"2021-11-05 20:20","market":"us","language":"en","title":"Vaccine stocks slipped after Pfizer announced its good news<blockquote>辉瑞宣布好消息后疫苗股下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1196545101","media":"Tiger Newspress","summary":"Vaccine stocks slipped after Pfizer announced his good news.Pfizer said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.BioNTech SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly and AstraZeneca fell between 1% and 11%.Whlie Pfizer surged 12% in premarket trading.","content":"<p>Vaccine stocks slipped after Pfizer announced his good news.Pfizer&nbsp;said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.</p><p><blockquote>辉瑞宣布他的好消息后，疫苗股下滑。辉瑞表示，其Covid-19药丸将高危患者的住院和死亡人数减少了89%。</blockquote></p><p> BioNTech&nbsp;SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 11%.Whlie&nbsp;Pfizer&nbsp;surged&nbsp;12%&nbsp;in premarket trading.</p><p><blockquote>BioNTech SE、Moderna、Novavax、默克、再生元制药、Vir Biotechnology、Inovio Pharmaceuticals、吉利德科学、礼来和AstraZeneca跌幅在1%至11%之间。辉瑞在盘前交易中飙升12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8a70ae8e53167b1da5670c9bd985e930\" tg-width=\"402\" tg-height=\"664\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks slipped after Pfizer announced its good news<blockquote>辉瑞宣布好消息后疫苗股下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks slipped after Pfizer announced its good news<blockquote>辉瑞宣布好消息后疫苗股下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-05 20:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks slipped after Pfizer announced his good news.Pfizer&nbsp;said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.</p><p><blockquote>辉瑞宣布他的好消息后，疫苗股下滑。辉瑞表示，其Covid-19药丸将高危患者的住院和死亡人数减少了89%。</blockquote></p><p> BioNTech&nbsp;SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 11%.Whlie&nbsp;Pfizer&nbsp;surged&nbsp;12%&nbsp;in premarket trading.</p><p><blockquote>BioNTech SE、Moderna、Novavax、默克、再生元制药、Vir Biotechnology、Inovio Pharmaceuticals、吉利德科学、礼来和AstraZeneca跌幅在1%至11%之间。辉瑞在盘前交易中飙升12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8a70ae8e53167b1da5670c9bd985e930\" tg-width=\"402\" tg-height=\"664\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","PFE":"辉瑞","BNTX":"BioNTech SE","VIR":"Vir Biotechnology, Inc.","REGN":"再生元制药公司","NVAX":"诺瓦瓦克斯医药","LLY":"礼来","INO":"伊诺维奥制药","MRK":"默沙东","MRNA":"Moderna, Inc.","GILD":"吉利德科学"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196545101","content_text":"Vaccine stocks slipped after Pfizer announced his good news.Pfizer said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%.\nBioNTech SE,Moderna,Novavax,Merck,Regeneron Pharmaceuticals,Vir Biotechnology,Inovio Pharmaceuticals,Gilead Sciences,Eli Lilly and AstraZeneca fell between 1% and 11%.Whlie Pfizer surged 12% in premarket trading.","news_type":1,"symbols_score_info":{"MRNA":0.9,"LLY":0.9,"GILD":0.9,"BNTX":0.9,"MRK":0.9,"NVAX":0.9,"AZN":0.9,"PFE":0.9,"VIR":0.9,"REGN":0.9,"INO":0.9}},"isVote":1,"tweetType":1,"viewCount":2308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}